Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer.

Solomon BJ, Liu G, Felip E, K Mok TS, Soo RA, Mazieres J, Shaw AT, Marinis F, Goto Y, Wu YL, Kim DW, Martini JF, Messina R, Paolini J, Polli A, Thomaidou D, Toffalorio F, Bauer TM

Open source

DOI: 10.1080/14796694.2024.2406117
Published: 2024 Dec
Container: Future oncology (London, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2024.2406117,
  title = {Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer.},
  author = {Solomon BJ and Liu G and Felip E and K Mok TS and Soo RA and Mazieres J and Shaw AT and Marinis F and Goto Y and Wu YL and Kim DW and Martini JF and Messina R and Paolini J and Polli A and Thomaidou D and Toffalorio F and Bauer TM},
  year = {2024},
  journal = {Future oncology (London, England)},
  doi = {10.1080/14796694.2024.2406117},
  url = {https://doi.org/10.1080/14796694.2024.2406117}
}

RIS

TY  - JOUR
TI  - Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer.
AU  - Solomon BJ
AU  - Liu G
AU  - Felip E
AU  - K Mok TS
AU  - Soo RA
AU  - Mazieres J
AU  - Shaw AT
AU  - Marinis F
AU  - Goto Y
AU  - Wu YL
AU  - Kim DW
AU  - Martini JF
AU  - Messina R
AU  - Paolini J
AU  - Polli A
AU  - Thomaidou D
AU  - Toffalorio F
AU  - Bauer TM
PY  - 2024
JO  - Future oncology (London, England)
DO  - 10.1080/14796694.2024.2406117
UR  - https://doi.org/10.1080/14796694.2024.2406117
ER  -

APA

BJ, S., G, L., E, F., TS, K. M., RA, S., J, M., AT, S., F, M., Y, G., YL, W., DW, K., JF, M., R, M., J, P., A, P., D, T., F, T., & TM, B. (2024). Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer.. Future oncology (London, England). https://doi.org/10.1080/14796694.2024.2406117

Source records

pubmed · retrieved 2026-09-26T15:43:32.957Z